Flotillin-1 in the substantia Nigra of the Parkinson brain and a predominant localization in catecholaminergic nerves in the rat brain

Neurotoxicity Research

Volumn 6, Issue 4, 2004, Pages 245-257

  Jacobowitz, D M ^a,b   Kallarakal, A T ^a,b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Cortex; Differential display; Dopamine; Locus coeruleus; Norepinephrine; Striatum

Indexed keywords

CATECHOLAMINE; FLOTILLINS; MEMBRANE PROTEIN; MESSENGER RNA;

AGED; ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMISTRY; COMPARATIVE STUDY; GENETICS; HUMAN; MALE; METABOLISM; NERVE FIBER; PARKINSON DISEASE; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; ANIMALS; CATECHOLAMINES; HUMANS; MALE; MEMBRANE PROTEINS; NERVE FIBERS; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBSTANTIA NIGRA;

EID: 21644441330     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033435     Document Type: Article

References (38)

1. Bankiewicz KS, RJ Plunkett, IJ Kopin, DM Jacobowitz, U di Porzio, WT London and EH Olfield (1990) Recovery from MPTP-induced parkinsonism in primates after fetal dopaminergic brain implants: Histochemical and behavioral studies. Histochemistry 93, 519-523.
2. Bauer SH, MF Wiechers, K Bruns, M Prybylski and CA Stuermer (2001) Isolation and identification of the plasma membrane-associated intracellular protein reggie-2 from goldfish brain by chromatography and Fourier-transform ion cyclotron resonance mass spectrometry. Anal. Biochem. 298, 25-31.
3. Baumann A, V Ribon, M Kanzaki, DC Thurmond, S Mora, S Shigematsu, PE Bickel, JE Pessin and AR Saltiel (2000) CAP defines a second signaling pathway required for insulin-stimulated glucose transport. Nature 407, 202-207.
4. Bickel PE, PE Scherer, JE Schnitzer, PM Oh, P Lisanti and HF Lodish (1997) Flotillin and epidermal surface antigen define a new family of caveole-associated integral membrane proteins. J. Biol. Chem. 272, 19793-19802.
5. Bing G, Y Zhang, Y Watanabe, B McEwen and E Stone (1994) Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra. Brain Res. 668, 261-265.
6. Björklund A and A Nobin (1973) Fluorescence histochemical and microspectrofluorometric mapping of dopamine and noradrena-line cell groups in the rat diencephalons. Brain Res. 51, 193-205.
7. Dahlström A and K Fuxe (1964) Existence of monoamine containing neurons in the cell bodies of brain stem neurons. Acta Physiol. Scand. 232, 1-53.
8. Fantini J, N Garmy, R Mahfoud and N Yahi (2002) Lipid rafts: Structure, function and role in HIV, Alzheimer's and prion diseases. Expert Rev. Mol. Med.: http://www.expertreviews.org/.
9. Foltynie T, S Sawcer, C Brayne and RA Barker (2002) The genetic basis of Parkinson's Disease. J. Neurol. Neurosurg. Psychiatry 73, 363-370.
10. Fuxe K (1965) Evidence for the existence of monoamine neurons in the central nervous system. IV. Distribution of monoamine nerve terminals in the central nervous system. Acta Physiol. Scand. 247, 38-85.
11. Galbiati F, V Daniela, JS Goltz, Z Steele, J Sen, J Jurcsak, D Stein, L Steven and MP Lisanti (1998) Identification, sequence and developmental expression of invertebrate flotillins from Drosophila melanogaster. Gene 210, 229-237.
12. Gwinn-Hardy K (2002) Genetics of parkinsonism. Mov. Disord. 17, 645-656.
13. Hökfelt T, R Märtensson, A Björklund, S Kleinan and M Goldstein (1984) Distributional maps of tyrosine-hydroxylase-immunoreactive neurons in the rat brain, In Handbook of Chemical Neuroanatomy, Vol. 2: Classical Transmitters in the CNS, Part I (Björklund A and T Hökfelt, Eds.) (Elsevier: New York, NY), pp 277-379.
14. Hornykiewicz O (1996) Dopamine (3-hydroxytryptamine) and brain function. Parmacol. Rev. 18, 925-963.
15. Jacobowitz DM (1974) Removal of discrete fresh regions of the rat brain. Brain Res. 80, 111-115.
16. Jacobowitz DM and M Palkovits (1974) Topographic atlas of catecholamine and acetylcholinesterase-containing neurons in the rat brain. I. Forebrain (telencephalon, diencephalon). J. Comp. Neurol. 157, 13-28.
17. Jellinger K (1991) Pathology of Parkinson's disease: Changes other than the nigrostriatal Pathway. Mol. Chem. Neuropathol. 14, 153-197.
18. Kokubo H, CA Lemere and H Yamaguchi (2000) Localization of flotillins in human brain and their accumulation with the progression of Alzheimer's disease pathology. Neurosci. Lett. 290, 93-96.
19. Kostrzewa RM and DM Jacobowitz (1974) Pharmacological actions of 6-hydroxydopamine. Pharmacol. Rev. 26, 199-288.
20. Lang DM, S Lommel, M Jung, R Ankerhold, B Petrausch, U Laessing, MF Wiechers, H Plattner and CAO Stuermer (1998) Fast track identification of reggie-1 and reggie-2 as plasma membrane-associated proteins which cocluster with activated GPI-anchored cell adhesion molecules in non-caveolar micropatches in neurons. J. Neurobiol. 37, 502-523.
21. Langston JW (2002) Parkinson's disease: Current and future challenges. Neurotoxicology 23, 443-450.
22. Liang P and AB Pardee (1995) Recent advances in differential display. Curr. Opin. Immunol. 7, 274-280.
23. Malaga-Trillo E, U Laessing, DM Lang, A Meyer and CA Stuermer (2002) Evolution of duplicated reggie genes in zebrafish and goldfish. J. Mol. Evol. 54, 235-245.
24. Mavridis M, AD Degryse, AJ Lategan, MR Marien and FC Colpaert (1991) Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys. Neuroscience 41, 507-523.
25. Palkovits M (1973) Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res. 59, 449-450.
26. Palkovits M and DM Jacobowitz (1974) Topographic atlas of catecholamine and acetylcholinesterase-containing neurons in the rat brain. II. Hindbrain (mesencephalon, rhombencephalon). J. Comp. Neurol. 157, 29-42.
27. Paxinos G and C Watson (1986) The Rat Brain in Stereotaxic Coordinates (Academic Press: New York, NY).
28. Petrausch B, R Tabibiazar, T Roser, Y Jing, D Goldman, CA Stuermer, N Irwin and LI Benowitz (2000) A purine-sensitive pathway regulates multiple genes involved in axon regeneration in goldfish retinal ganglion cells. J. Neurosci. 20, 8031-8041.
29. Pycock CJ, IM Donaldson and CD Marsden (1975) Circling behaviour produced by unilateral lesions in the region of the locus coeruleus in rats. Brain Res. 97, 317-329.
30. Salzer U and R Prohaska (2001) Stomatin, flotillin-1 and flotillin-2 are major integral proteins of erythrocytes lipid rafts. Blood 97, 1141-1143.
31. Schapira AH (1994) Evidence for mitochondrial dysfunction in Parkinson's disease - a critical appraisal. Mov. Disord. 9, 125-138.
32. Schroeder W, S Stewart-Galetka, DA Parry, D Goldsmith and ML Duvic (1994) Cloning and characterization of a novel epidermal cell surface antigen (ESA). J. Biol. Chem. 269, 19983-19991.
33. Schulte T, KA Paschke, U Laessing, F Lottspeich and CAO Stuermer (1997) Reggie-1 and reggie-2, two cell surface proteins expressed by retinal ganglion cells during axon regeneration. Development 124, 577-587.
34. Stuermer CAO, DM Lang, F Kirsch, M Wiechers, SO Deininger and H Plattner (2001) Glycosylphosphatidyl inositol-anchored proteins and fyn kinase assemble in noncaveolar plasma membrane microdomains defined by reggie-1 and reggie-2. Mol. Biol. Cell 12, 3031-3045.
35. Suzuki T (2002) Lipid rafts at postsynaptic sites: Distribution, function and linkage to postsynaptic density. Neurosci. Res. 44, 1-9.
36. Volonte D, F Galbiati, S Li, K Nishiyama, T Okamoto and MP Lisanti (1999) Flotillins/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo: characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probe. J. Biol. Chem. 274, 12702-12709.
37. Weinstock M, AP Zavadil, EA Muth, WR Crowley, TL O'Donohue, DM Jacobowitz and IJ Kopin (1980) Evidence that noradrenaline modulates the increase in striatal dopamine metabolism induced by muscarinic receptor stimulation. Eur. J. Pharm. 68, 427-435.
38. Zarow C, SA Lyness, JA Mortimer and HC Chui (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch. Neurol. 60, 337-341.